These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16766332)

  • 1. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
    Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE; Clarke S
    J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with acitretin for psoriasis.
    Hodulik SG; Zeichner JA
    J Dermatolog Treat; 2006; 17(2):108-11. PubMed ID: 16766335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
    Smith EC; Riddle C; Menter MA; Lebwohl M
    Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 8. Acitretin is a safe treatment option for infantile pustular psoriasis.
    Ergin S; Ersoy-Evans S; Sahin S; Ozkaya O
    J Dermatolog Treat; 2008; 19(6):341-3. PubMed ID: 18608713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment strategy for psoriasis: transitioning from systemic therapy to biologic agents.
    Ortiz A; Yamauchi PS
    Skinmed; 2006; 5(6):285-8. PubMed ID: 17085995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
    Yelverton CB; Yentzer BA; Clark A; Pearce DJ; Balkrishnan R; Camacho FT; Boles A; Fleischer AB; Feldman SR
    Arch Dermatol; 2008 Sep; 144(9):1224-5. PubMed ID: 18794474
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis.
    Ezquerra GM; Regaña MS; Millet PU
    Acta Derm Venereol; 2007; 87(5):449-50. PubMed ID: 17721663
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent dosing of biologics for psoriasis.
    Feldman SR
    J Dermatolog Treat; 2006; 17(1):5. PubMed ID: 16467016
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
    Krell JM
    J Am Acad Dermatol; 2006 Jun; 54(6):1099-101. PubMed ID: 16713481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
    Young MS; Horn EJ; Cather JC
    Expert Rev Clin Immunol; 2011 Jan; 7(1):9-13. PubMed ID: 21162644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
    Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.